DGX vs. SOLV: Quest Diagnostics vs. Solventum Stock Comparison

November 11, 2026

How do Quest Diagnostics (DGX) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Quest Diagnostics (DGX) and Solventum (SOLV) both fall under the Health Care Equipment & Services industry group, but DGX is classified in Health Care Providers & Services while SOLV is classified in Health Care Equipment & Supplies.

Quest Diagnostics (DGX) carries decades of public-market history since December 17, 1996, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the DGX side.

Company profile comparison for Quest Diagnostics (DGX) and Solventum (SOLV)
Profile Item	DGX	SOLV
Name	Quest Diagnostics Incorporated	Solventum Corporation
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Providers & Services	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Services	Health Care Supplies
Market Capitalization	28.21 billion USD	15.36 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	December 17, 1996	March 26, 2024
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

DGX

SOLV

GSPC

Quest Diagnostics (DGX) vs. Solventum (SOLV), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Quest Diagnostics (DGX) and Solventum (SOLV). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Quest Diagnostics (DGX) and Solventum (SOLV). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
Total Return (1Y)	45.88%	25.89%
Total Return (3Y, Annualized)	27.45%	--
Total Return (5Y, Annualized)	14.84%	--

Risk Profile

Drawdown History

DGX

SOLV

GSPC

Quest Diagnostics (DGX) vs. Solventum (SOLV), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Quest Diagnostics (DGX) and Solventum (SOLV). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
Volatility (1Y, Annualized)	24.06%	30.06%
Beta (5Y)	0.54	0.62
Max Drawdown (5Y)	-28.62%	-39.98%
Avg. Volume (3M)	1.00M	1.05M

Risk-Adjusted Performance

Risk-Return Positioning

DGX and SOLV are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
Sharpe Ratio (1Y)	1.73	0.72
Sortino Ratio (1Y)	3.16	1.08

Profitability

ROE (TTM)

Quest Diagnostics (DGX) at 15.32% sits in the top ROE quartile, while Solventum (SOLV) at 3.19% is closer to the peer norm — stronger capital efficiency for DGX.

DGX

Health Care Equipment & Services industry group

15.32%

Max: 47.61%
DGX: 15.32%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

SOLV

Health Care Equipment & Services industry group

3.19%

Max: 47.61%
Q3: 14.36%
Median: 5.45%
SOLV: 3.19%
Q1: -10.67%
Min: -47.01%

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

Quest Diagnostics (DGX) at 9.54% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.

DGX

Health Care Equipment & Services industry group

9.54%

Max: 29.35%
DGX: 9.54%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

SOLV

Health Care Equipment & Services industry group

1.91%

Max: 29.35%
Q3: 9.33%
Median: 2.18%
SOLV: 1.91%
Q1: -6.29%
Min: -28.46%

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Quest Diagnostics (DGX) at 15.63% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.

DGX

Health Care Equipment & Services industry group

15.63%

Max: 35.43%
DGX: 15.63%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

SOLV

Health Care Equipment & Services industry group

6.82%

Max: 35.43%
Q3: 14.14%
SOLV: 6.82%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
ROE (TTM)	15.32%	3.19%
ROA (TTM)	6.61%	2.29%
Net Margin (TTM)	9.54%	1.91%
Operating Margin (TTM)	15.63%	6.82%
Gross Margin (TTM)	33.18%	55.13%

Growth

Revenue Growth

Quest Diagnostics (DGX) at 11.78% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their Revenue Growth across different time periods.

EPS Growth

Solventum (SOLV) at 221.74% clears its industry range for EPS growth, a much stronger earnings trajectory than Quest Diagnostics (DGX) at 13.78%, which is closer to a typical peer reading.

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
Revenue Growth (YoY)	11.78%	0.86%
Revenue Growth (3Y CAGR)	3.74%	0.79%
EPS Growth (YoY)	13.78%	221.74%
EPS Growth (3Y CAGR)	3.16%	4.51%

Financial Strength

Current Ratio (MRQ)

Quest Diagnostics (DGX) at 1.70 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.

DGX

Health Care Equipment & Services industry group

1.70

Max: 7.59
Q3: 4.00
Median: 1.98
DGX: 1.70
Q1: 1.37
Min: 0.30

SOLV

Health Care Equipment & Services industry group

1.03

Max: 7.59
Q3: 4.00
Median: 1.98
Q1: 1.37
SOLV: 1.03
Min: 0.30

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Quest Diagnostics (DGX) at 0.80 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.

DGX

Health Care Equipment & Services industry group

0.80

Max: 1.88
Q3: 0.91
DGX: 0.80
Median: 0.58
Q1: 0.16
Min: 0.00

SOLV

Health Care Equipment & Services industry group

1.10

Max: 1.88
SOLV: 1.10
Q3: 0.91
Median: 0.58
Q1: 0.16
Min: 0.00

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
Current Ratio (MRQ)	1.70	1.03
Debt / Equity (MRQ)	0.80	1.10
Net Debt / EBITDA	2.38	4.66

Dividends

Dividend Yield (TTM)

Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a yield of 1.33%, ranking against industry peers normally.

DGX

Health Care Equipment & Services industry group

1.33%

DGX: 1.33%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SOLV

Health Care Equipment & Services industry group

0.00%

SOLV: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a payout of 25.10%, ranking against industry peers normally.

DGX

Health Care Equipment & Services industry group

25.10%

DGX: 25.10%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SOLV

Health Care Equipment & Services industry group

0.00%

SOLV: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
Dividend Yield (TTM)	1.33%	0.00%
Dividend Payout Ratio (TTM)	25.10%	0.00%

Valuation

P/E Ratio (TTM)

Quest Diagnostics (DGX) at 25.46 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.

DGX

Health Care Equipment & Services industry group

25.46

Max: 80.41
Q3: 47.62
Median: 29.93
DGX: 25.46
Q1: 21.19
Min: 4.21

SOLV

Health Care Equipment & Services industry group

101.55

SOLV: 101.55
Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
Min: 4.21

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both Quest Diagnostics (DGX) at 2.38 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

DGX

Health Care Equipment & Services industry group

2.38

Max: 8.80
Q3: 4.32
DGX: 2.38
Median: 2.13
Q1: 1.10
Min: 0.03

SOLV

Health Care Equipment & Services industry group

1.88

Max: 8.80
Q3: 4.32
Median: 2.13
SOLV: 1.88
Q1: 1.10
Min: 0.03

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Quest Diagnostics (DGX) at 3.68 and Solventum (SOLV) at 3.20 are valued close to their industries’ norm against book — neither stands out from peers.

DGX

Health Care Equipment & Services industry group

3.68

Max: 11.68
Q3: 6.12
DGX: 3.68
Median: 3.00
Q1: 1.73
Min: -1.31

SOLV

Health Care Equipment & Services industry group

3.20

Max: 11.68
Q3: 6.12
SOLV: 3.20
Median: 3.00
Q1: 1.73
Min: -1.31

Quest Diagnostics (DGX) vs. Solventum (SOLV): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Quest Diagnostics (DGX) and Solventum (SOLV)
Metric	DGX	SOLV
P/E Ratio (TTM)	25.46	101.55
P/S Ratio (TTM)	2.38	1.88
P/B Ratio (MRQ)	3.68	3.20
Free Cash Flow Yield (TTM)	3.09%	1.31%